Radar Telegram alerts Open Radar

The phase 3 PIVOT-006 registration trial demonstrates an unprecedented improvement in recurrence-free survival (RFS) for intermediate- and high-grade Ta Non-Muscle Invasive Bladder Cancer (NMIBC).

תרגם לעברית

Business Insider Markets · · Source

The phase 3 PIVOT-006 registration trial demonstrates an unprecedented improvement in recurrence-free survival (RFS) for intermediate- and high-grade Ta Non-Muscle Invasive Bladder Cancer (NMIBC).

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram